Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs

HERZLIYA, Israel and CALGARY, AB, Nov. 26, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to report positive results from a basic safety assessment...